Jorge Ferrandiz-Mestre

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Pricing Combination Therapies: A Systematic Review of Value Attribution, Cost-Sharing Mechanisms and Policy Frameworks.

Pricing Combination Therapies: A Systematic Review of Value Attribution, Cost-Sharing Mechanisms and Policy Frameworks.

Journal: Applied health economics and health policy

Published: April 19, 2026

Transferable Exclusivity Extension Vouchers for Antimicrobials: Incentive Design, Implementation Challenges, and Policy Trade-Offs.

Transferable Exclusivity Extension Vouchers for Antimicrobials: Incentive Design, Implementation Challenges, and Policy Trade-Offs.

Journal: PharmacoEconomics - open

Published: November 22, 2025

Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreements.

Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreements.

Journal: BMJ (Clinical research ed.)

Published: November 11, 2025

Policies to promote affordability and access across the life cycle of costly new drugs.

Policies to promote affordability and access across the life cycle of costly new drugs.

Journal: BMJ (Clinical research ed.)

Published: November 11, 2025

A Framework for Considering the Role of the Public Sector in R&D of Health Technology.

A Framework for Considering the Role of the Public Sector in R&D of Health Technology.

Journal: Pharmaceutical medicine

Published: June 26, 2025

Cost-per-Responder Analysis of Bimekizumab (IL-17A/F Inhibitor) Against IL-Inhibitors for Psoriatic Arthritis in Spain, Based on Matching-Adjusted Indirect Comparisons.

Cost-per-Responder Analysis of Bimekizumab (IL-17A/F Inhibitor) Against IL-Inhibitors for Psoriatic Arthritis in Spain, Based on Matching-Adjusted Indirect Comparisons.

Journal: Rheumatology and therapy

Published: June 11, 2025

Patient Expectations in Allergic Rhinitis Treatment: A Mixed-Methods Study.

Patient Expectations in Allergic Rhinitis Treatment: A Mixed-Methods Study.

Journal: Patient preference and adherence

Published: March 05, 2025

Impact of Increased Single-Inhaler Triple Therapy Use in Appropriate Patients on Chronic Obstructive Pulmonary Disease Exacerbations, Mortality, and Medical Costs: PROMETHEUS Spain.

Impact of Increased Single-Inhaler Triple Therapy Use in Appropriate Patients on Chronic Obstructive Pulmonary Disease Exacerbations, Mortality, and Medical Costs: PROMETHEUS Spain.

Journal: Respiration; international review of thoracic diseases

Published: January 29, 2025

Academic Drug Discovery Units in the UK: Progress and challenges.

Academic Drug Discovery Units in the UK: Progress and challenges.

Journal: Drug discovery today

Published: September 12, 2024

Parent's perception of respiratory syncytial virus and subsequent wheezing burden: A multi-country cross-sectional survey.

Parent's perception of respiratory syncytial virus and subsequent wheezing burden: A multi-country cross-sectional survey.

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Published: March 25, 2024

Collaboration for new therapies: maximizing health and innovation.

Collaboration for new therapies: maximizing health and innovation.

Journal: Frontiers in public health

Published: February 08, 2024

Leveraging the holistic benefits of biosimilars in Europe - part 2: how payers can safeguard the future of a healthy biosimilar market environment.

Leveraging the holistic benefits of biosimilars in Europe - part 2: how payers can safeguard the future of a healthy biosimilar market environment.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: January 29, 2024

Showing 1-12 of 55

Last Updated: 09/26/2026